Table 5. Summary of management pathway for solitary part-solid (>50% Ground glass) nodules by ACCP guideline.

Size (mm)	Management pathway
≤8	CT surveillance*
>8, ≤15	CT surveillance with optional PET/CT**, biopsy and/or resection
>15	PET/CT, biopsy

*, timing and term of CT surveillance depend on nodule size and appearance; **, PET/CT should not be used to characterize part-solid nodules in which the solid component measures ≤8 mm; ACCP, American College of Clinical Pharmacy; CT, computed tomography; PET, positron emission tomography.